Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Nilotinib interferes with cell cycle, ABC transporters and JAK-STAT signaling pathway in CD34+/lin- cells of patients with chronic phase chronic myeloid leukemia after 12 months of treatment.

Trojani A, Pungolino E, Dal Molin A, Lodola M, Rossi G, D'Adda M, Perego A, Elena C, Turrini M, Borin L, Bucelli C, Malato S, Carraro MC, Spina F, Latargia ML, Artale S, Spedini P, Anghilieri M, Di Camillo B, Baruzzo G, De Canal G, Iurlo A, Morra E, Cairoli R.

PLoS One. 2019 Jul 18;14(7):e0218444. doi: 10.1371/journal.pone.0218444. eCollection 2019.

2.

Nature and Topology of Metal-Oxygen Binding Sites in Zeolite Materials: 17 O High-Resolution EPR Spectroscopy of Metal-Loaded ZSM-5.

Morra E, Signorile M, Salvadori E, Bordiga S, Giamello E, Chiesa M.

Angew Chem Int Ed Engl. 2019 Jul 11. doi: 10.1002/anie.201906488. [Epub ahead of print]

PMID:
31294524
3.

Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.

Rattotti S, Ferretti VV, Rusconi C, Rossi A, Fogazzi S, Baldini L, Pioltelli P, Balzarotti M, Farina L, Ferreri AJM, Laszlo D, Speziale V, Varettoni M, Sciarra R, Morello L, Tedeschi A, Frigeni M, Defrancesco I, Zerbi C, Flospergher E, Nizzoli ME, Morra E, Arcaini L; “Rete Ematologica Lombarda” (REL - Hematology Clinical Network of Lombardy - Lymphoma Workgroup).

Hematol Oncol. 2019 Apr;37(2):160-167. doi: 10.1002/hon.2575. Epub 2019 Feb 22.

PMID:
30726562
4.

Endurance training restores spatially distinct cardiac mitochondrial function and myocardial contractility in ovariectomized rats.

Morra EA, Rodrigues PL, Jesus ICG, Do Val Lima PR, Ávila RA, Zanardo TÉC, Nogueira BV, Bers DM, Guatimosim S, Stefanon I, Ribeiro Júnior RF.

Free Radic Biol Med. 2019 Jan;130:174-188. doi: 10.1016/j.freeradbiomed.2018.10.406. Epub 2018 Oct 10.

PMID:
30315935
5.

A Rare Example of Four-Coordinate Nonoxido Vanadium(IV) Alkoxide in the Solid State: Structure, Spectroscopy, and Magnetization Dynamics.

Stinghen D, Atzori M, Fernandes CM, Ribeiro RR, de Sá EL, Back DF, Giese SOK, Hughes DL, Nunes GG, Morra E, Chiesa M, Sessoli R, Soares JF.

Inorg Chem. 2018 Sep 17;57(18):11393-11403. doi: 10.1021/acs.inorgchem.8b01117. Epub 2018 Aug 30.

PMID:
30160486
6.

Scaling Up Electronic Spin Qubits into a Three-Dimensional Metal-Organic Framework.

Yamabayashi T, Atzori M, Tesi L, Cosquer G, Santanni F, Boulon ME, Morra E, Benci S, Torre R, Chiesa M, Sorace L, Sessoli R, Yamashita M.

J Am Chem Soc. 2018 Sep 26;140(38):12090-12101. doi: 10.1021/jacs.8b06733. Epub 2018 Sep 17.

PMID:
30145887
7.

A two-qubit molecular architecture for electron-mediated nuclear quantum simulation.

Atzori M, Chiesa A, Morra E, Chiesa M, Sorace L, Carretta S, Sessoli R.

Chem Sci. 2018 Jun 15;9(29):6183-6192. doi: 10.1039/c8sc01695j. eCollection 2018 Aug 7.

8.

Nilotinib induced bone marrow CD34+/lin-Ph+ cells early clearance in newly diagnosed CP-chronic myeloid leukemia.

Pungolino E, Rossi G, De Canal G, Trojani A, D'adda M, Perego A, Orlandi EM, Lunghi F, Turrini M, Borin L, Iurlo A, Latargia ML, Carraro MC, Spina F, Lodola M, Artale S, Anghilieri M, Spedini P, Cantoni S, Di Camillo B, Morra E, Cairoli R.

Am J Hematol. 2018 Jul;93(7):E162-E164. doi: 10.1002/ajh.25106. Epub 2018 May 17. No abstract available.

9.

Structural Effects on the Spin Dynamics of Potential Molecular Qubits.

Atzori M, Benci S, Morra E, Tesi L, Chiesa M, Torre R, Sorace L, Sessoli R.

Inorg Chem. 2018 Jan 16;57(2):731-740. doi: 10.1021/acs.inorgchem.7b02616. Epub 2017 Dec 27.

PMID:
29280628
10.

Wide-transcriptome analysis and cellularity of bone marrow CD34+/lin- cells of patients with chronic-phase chronic myeloid leukemia at diagnosis vs. 12 months of first-line nilotinib treatment.

Trojani A, Pungolino E, Rossi G, D'Adda M, Lodola M, Camillo BD, Perego A, Turrini M, Orlandi E, Borin L, Iurlo A, Malato S, Spina F, Latargia ML, Lanza F, Artale S, Anghilieri M, Carraro MC, Canal G, Morra E, Cairoli R.

Cancer Biomark. 2017 Dec 12;21(1):41-53. doi: 10.3233/CBM-170209.

PMID:
29036785
11.

[Cardiologists and mucopolysaccharidoses. Recommendations of GICEM (Cardiology Experts on Metabolic Disease Italian Group) for diagnosis, follow-up and cardiological management].

Russo P, Andria G, Baldinelli A, Boffi ML, Cerini E, Della Casa R, Imperatori A, Luciani GB, Morra E, Parini R, Pieroni M, Prioli MA, Ragni L, Rapezzi C, Rinelli G, Rubino M, Sarais C, Sciacca P, Seddio F, Limongelli G.

G Ital Cardiol (Rome). 2017 Sep;18(9):638-649. doi: 10.1714/2741.27947. Italian.

PMID:
28845875
12.

EPR approaches to heterogeneous catalysis. The chemistry of titanium in heterogeneous catalysts and photocatalysts.

Morra E, Giamello E, Chiesa M.

J Magn Reson. 2017 Jul;280:89-102. doi: 10.1016/j.jmr.2017.02.008.

PMID:
28579105
13.

Estrogen regulates spatially distinct cardiac mitochondrial subpopulations.

Ribeiro Junior RF, Rodrigues PL, Morra EA, Ronconi KS, Do Val Lima PR, Porto ML, Simões MR, Vassallo DV, Figueiredo SG, Stefanon I.

Mitochondrion. 2017 Jul;35:87-96. doi: 10.1016/j.mito.2017.05.011. Epub 2017 May 29.

PMID:
28572055
14.

Quantum Coherence Times Enhancement in Vanadium(IV)-based Potential Molecular Qubits: the Key Role of the Vanadyl Moiety.

Atzori M, Morra E, Tesi L, Albino A, Chiesa M, Sorace L, Sessoli R.

J Am Chem Soc. 2016 Sep 7;138(35):11234-44. doi: 10.1021/jacs.6b05574. Epub 2016 Aug 26.

PMID:
27517709
15.

Unraveling the Catalytic Synergy between Ti(3+) and Al(3+) Sites on a Chlorinated Al2 O3 : A Tandem Approach to Branched Polyethylene.

Piovano A, Thushara KS, Morra E, Chiesa M, Groppo E.

Angew Chem Int Ed Engl. 2016 Sep 5;55(37):11203-6. doi: 10.1002/anie.201604136. Epub 2016 Jul 21.

16.

Treatment recommendations from the Eighth International Workshop on Waldenström's Macroglobulinemia.

Leblond V, Kastritis E, Advani R, Ansell SM, Buske C, Castillo JJ, García-Sanz R, Gertz M, Kimby E, Kyriakou C, Merlini G, Minnema MC, Morel P, Morra E, Rummel M, Wechalekar A, Patterson CJ, Treon SP, Dimopoulos MA.

Blood. 2016 Sep 8;128(10):1321-8. doi: 10.1182/blood-2016-04-711234. Epub 2016 Jul 18. Review.

17.

Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia.

Castillo JJ, Garcia-Sanz R, Hatjiharissi E, Kyle RA, Leleu X, McMaster M, Merlini G, Minnema MC, Morra E, Owen RG, Poulain S, Stone MJ, Tam C, Varettoni M, Dimopoulos MA, Treon SP, Kastritis E.

Br J Haematol. 2016 Oct;175(1):77-86. doi: 10.1111/bjh.14196. Epub 2016 Jul 5.

18.

Sex differences in the regulation of spatially distinct cardiac mitochondrial subpopulations.

Ribeiro RF Jr, Ronconi KS, Morra EA, Do Val Lima PR, Porto ML, Vassallo DV, Figueiredo SG, Stefanon I.

Mol Cell Biochem. 2016 Aug;419(1-2):41-51. doi: 10.1007/s11010-016-2748-4. Epub 2016 Jul 2.

PMID:
27370644
19.

Feasibility of abiraterone acetate treatment in patients with metastatic castration-resistant prostate cancer and atrial fibrillation.

Rauch S, Fong D, Morra E, Maines F, Caffo O, Spizzo G.

Prostate Int. 2016 Jun;4(2):54-5. doi: 10.1016/j.prnil.2016.02.002. Epub 2016 Feb 21.

20.

Quantum coherence in a processable vanadyl complex: new tools for the search of molecular spin qubits.

Tesi L, Lucaccini E, Cimatti I, Perfetti M, Mannini M, Atzori M, Morra E, Chiesa M, Caneschi A, Sorace L, Sessoli R.

Chem Sci. 2016 Mar 1;7(3):2074-2083. doi: 10.1039/c5sc04295j. Epub 2015 Dec 11.

21.

Room-Temperature Quantum Coherence and Rabi Oscillations in Vanadyl Phthalocyanine: Toward Multifunctional Molecular Spin Qubits.

Atzori M, Tesi L, Morra E, Chiesa M, Sorace L, Sessoli R.

J Am Chem Soc. 2016 Feb 24;138(7):2154-7. doi: 10.1021/jacs.5b13408. Epub 2016 Feb 11.

PMID:
26853512
22.

The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda".

Molteni A, Riva M, Borin L, Bernardi M, Pelizzari AM, Freyrie A, Della Porta M, Nichelatti M, Ravano E, Quaresmini G, Mariotti J, Caramazza D, Ubezio M, Guarco S, Gigli F, Greco R, Cairoli R, Morra E.

Leuk Res. 2016 Mar;42:21-7. doi: 10.1016/j.leukres.2016.01.006. Epub 2016 Jan 18.

PMID:
26852003
23.

Clonal architecture of CXCR4 WHIM-like mutations in Waldenström Macroglobulinaemia.

Xu L, Hunter ZR, Tsakmaklis N, Cao Y, Yang G, Chen J, Liu X, Kanan S, Castillo JJ, Tai YT, Zehnder JL, Brown JR, Carrasco RD, Advani R, Sabile JM, Argyropoulos K, Lia Palomba M, Morra E, Trojani A, Greco A, Tedeschi A, Varettoni M, Arcaini L, Munshi NM, Anderson KC, Treon SP.

Br J Haematol. 2016 Mar;172(5):735-44. doi: 10.1111/bjh.13897. Epub 2015 Dec 13.

24.

Probing the coordination environment of Ti(3+) ions coordinated to nitrogen-containing Lewis bases.

Morra E, Maurelli S, Chiesa M, Van Doorslaer S.

Phys Chem Chem Phys. 2015 Aug 28;17(32):20853-60. doi: 10.1039/c5cp03417e. Epub 2015 Jul 27.

25.

Feasibility of romiplostim discontinuation in adult thrombopoietin-receptor agonist responsive patients with primary immune thrombocytopenia: an observational retrospective report in real life clinical practice.

Carpenedo M, Cantoni S, Coccini V, Fedele M, Morra E, Pogliani EM.

Hematol Rep. 2015 Feb 24;7(1):5673. doi: 10.4081/hr.2015.5673. eCollection 2015 Feb 24.

26.

Impact of allogeneic stem cell transplantation on survival of patients less than 65 years of age with primary myelofibrosis.

Kröger N, Giorgino T, Scott BL, Ditschkowski M, Alchalby H, Cervantes F, Vannucchi A, Cazzola M, Morra E, Zabelina T, Maffioli M, Pereira A, Beelen D, Deeg HJ, Passamonti F.

Blood. 2015 May 21;125(21):3347-50; quiz 3364. doi: 10.1182/blood-2014-10-608315. Epub 2015 Mar 17.

27.

Post-remission intensive treatment after induction chemotherapy is feasible in selected elderly patients with acute myeloid leukemia and age ≥75 years: a retrospective analysis of the Rete Ematologica Lombarda.

Bernardi M, Zappasodi P, Fracchiolla N, Marbello L, Todisco E, Pagani C, Carrabba M, Rossi M, Guidotti F, Mancini V, Santoro A, Borlenghi E, Ciceri F, Morra E, Rossi G.

Am J Hematol. 2015 Jun;90(6):E123-5. doi: 10.1002/ajh.23990. Epub 2015 May 3. No abstract available.

28.

Probing the coordinative unsaturation and local environment of Ti³⁺ sites in an activated high-yield Ziegler-Natta catalyst.

Morra E, Giamello E, Van Doorslaer S, Antinucci G, D'Amore M, Busico V, Chiesa M.

Angew Chem Int Ed Engl. 2015 Apr 13;54(16):4857-60. doi: 10.1002/anie.201412052. Epub 2015 Feb 23.

29.

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

Tedeschi A, Picardi P, Ferrero S, Benevolo G, Margiotta Casaluci G, Varettoni M, Baratè C, Motta M, Gini G, Goldaniga MC, Visco C, Zaja F, Belsito Petrizi V, Ravelli E, Gentile M, Urbano MA, Franceschetti S, Ghione P, Orsucci L, Frustaci AM, Gaidano G, Vitolo U, Morra E.

Leuk Lymphoma. 2015;56(9):2637-42. doi: 10.3109/10428194.2015.1012714. Epub 2015 Mar 14.

PMID:
25651423
30.

Autologous stem cell transplantation with in vivo purged progenitor cells shows long-term efficacy in relapsed/refractory follicular lymphoma.

Arcaini L, Morello L, Tucci A, Rusconi C, Ladetto M, Rattotti S, Bonfichi M, Bottelli C, Gabutti C, Bernasconi P, Varettoni M, Gotti M, Troletti D, Guerrera ML, Fiaccadori V, Sciarra R, Ferretti VV, Alessandrino EP, Rossi G, Morra E.

Am J Hematol. 2015 Mar;90(3):230-4. doi: 10.1002/ajh.23919.

31.

Prognostic relevance of the flow cytometric count of medullar blasts in myelodysplastic syndromes.

Molteni A, Riva M, Cesana C, Speziale V, Nichelatti M, Scarpati B, Greco R, Ravano E, Cairoli R, Rossini S, Morra E.

Eur J Haematol. 2015 Jun;94(6):519-25. doi: 10.1111/ejh.12465. Epub 2014 Dec 4.

PMID:
25307971
32.

Rapid clearance of HCV-related splenic marginal zone lymphoma under an interferon-free, NS3/NS4A inhibitor-based treatment. A case report.

Rossotti R, Travi G, Pazzi A, Baiguera C, Morra E, Puoti M.

J Hepatol. 2015 Jan;62(1):234-7. doi: 10.1016/j.jhep.2014.09.031. Epub 2014 Oct 5.

PMID:
25285757
33.

Ruxolitinib and survival improvement in patients with myelofibrosis.

Passamonti F, Vannucchi AM, Cervantes F, Harrison C, Morra E, Kantarjian H, Verstovsek S.

Leukemia. 2015 Mar;29(3):739-40. doi: 10.1038/leu.2014.282. Epub 2014 Sep 24. No abstract available.

PMID:
25249013
34.

EPR investigation of TiCl3 dissolved in polar solvents--implications for the understanding of active Ti(III) species in heterogeneous Ziegler-Natta catalysts.

Maurelli S, Morra E, Van Doorslaer S, Busico V, Chiesa M.

Phys Chem Chem Phys. 2014 Sep 28;16(36):19625-33. doi: 10.1039/c4cp02722a.

PMID:
25109263
35.

Carfilzomib: a new opportunity for WM patients.

Morra E.

Blood. 2014 Jul 24;124(4):468-9. doi: 10.1182/blood-2014-06-578625. No abstract available.

36.

Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus.

Dimopoulos MA, Kastritis E, Owen RG, Kyle RA, Landgren O, Morra E, Leleu X, García-Sanz R, Munshi N, Anderson KC, Terpos E, Ghobrial IM, Morel P, Maloney D, Rummel M, Leblond V, Advani RH, Gertz MA, Kyriakou C, Thomas SK, Barlogie B, Gregory SA, Kimby E, Merlini G, Treon SP.

Blood. 2014 Aug 28;124(9):1404-11. doi: 10.1182/blood-2014-03-565135. Epub 2014 Jul 15. Review.

37.

Bendamustine and subcutaneous alemtuzumab combination is an effective treatment in relapsed/refractory chronic lymphocytic leukemia patients.

Montillo M, Tedeschi A, Gaidano G, Coscia M, Petrizzi VB, Orlandi E, Cascavilla N, Ghia P, Motta M, Gallamini A, Frustaci AM, Rossi D, De Paoli L, Nichelatti M, Morra E, Massaia M.

Haematologica. 2014 Sep;99(9):e159-61. doi: 10.3324/haematol.2014.106740. Epub 2014 Jun 27. No abstract available.

38.

Minimal morphological criteria for defining bone marrow dysplasia: a basis for clinical implementation of WHO classification of myelodysplastic syndromes.

Della Porta MG, Travaglino E, Boveri E, Ponzoni M, Malcovati L, Papaemmanuil E, Rigolin GM, Pascutto C, Croci G, Gianelli U, Milani R, Ambaglio I, Elena C, Ubezio M, Da Via' MC, Bono E, Pietra D, Quaglia F, Bastia R, Ferretti V, Cuneo A, Morra E, Campbell PJ, Orazi A, Invernizzi R, Cazzola M; Rete Ematologica Lombarda (REL) Clinical Network.

Leukemia. 2015 Jan;29(1):66-75. doi: 10.1038/leu.2014.161. Epub 2014 May 20.

PMID:
24935723
39.

Heart rate at 4 s after the onset of exercise in endurance-trained men.

Zaniqueli D, Morra EA, Dantas EM, Baldo MP, Carletti L, Perez AJ, Rodrigues SL, Mill JG.

Can J Physiol Pharmacol. 2014 Jun;92(6):476-80. doi: 10.1139/cjpp-2014-0042. Epub 2014 Apr 26.

PMID:
24886303
40.

Probing the redox chemistry of titanium silicalite-1: formation of tetrahedral Ti3+ centers by reaction with triethylaluminum.

Morra E, Giamello E, Chiesa M.

Chemistry. 2014 Jun 10;20(24):7381-8. doi: 10.1002/chem.201304139. Epub 2014 May 13.

PMID:
24824439
41.

Impact of ruxolitinib on the natural history of primary myelofibrosis: a comparison of the DIPSS and the COMFORT-2 cohorts.

Passamonti F, Maffioli M, Cervantes F, Vannucchi AM, Morra E, Barbui T, Caramazza D, Pieri L, Rumi E, Gisslinger H, Knoops L, Kiladjian JJ, Mora B, Hollaender N, Pascutto C, Harrison C, Cazzola M.

Blood. 2014 Mar 20;123(12):1833-5. doi: 10.1182/blood-2013-12-544411. Epub 2014 Jan 17.

42.

Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013.

Breccia M, Alimena G, Baccarani M, Bocchia M, Di Raimondo F, Gambacorti-Passerini C, Gozzini A, Morra E, Pane F, Pregno P, Rege-Cambrin G, Rosti G, Specchia G, Vigneri P, Saglio G.

Crit Rev Oncol Hematol. 2014 Jun;90(3):181-9. doi: 10.1016/j.critrevonc.2013.12.010. Epub 2013 Dec 17.

PMID:
24405858
43.

Long-term intense resistance training in men is associated with preserved cardiac structure/function, decreased aortic stiffness, and lower central augmentation pressure.

Morra EA, Zaniqueli D, Rodrigues SL, El-Aouar LM, Lunz W, Mill JG, Carletti L.

J Hypertens. 2014 Feb;32(2):286-93. doi: 10.1097/HJH.0000000000000035.

PMID:
24351804
44.

Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience.

Nosari AM, Pioltelli ML, Riva M, Marbello L, Nichelatti M, Greco A, Molteni A, Vismara E, Gabutti C, Volonterio A, Lombardi P, Morra E.

Leuk Lymphoma. 2014 Aug;55(8):1844-8. doi: 10.3109/10428194.2013.853299. Epub 2014 Feb 4.

PMID:
24138328
45.

Associated cancers in Waldenström macroglobulinemia: clues for common genetic predisposition.

Morra E, Varettoni M, Tedeschi A, Arcaini L, Ricci F, Pascutto C, Rattotti S, Vismara E, Paris L, Cazzola M.

Clin Lymphoma Myeloma Leuk. 2013 Dec;13(6):700-3. doi: 10.1016/j.clml.2013.05.008. Epub 2013 Sep 24.

PMID:
24070824
46.

Management recommendations for chronic myelomonocytic leukemia: consensus statements from the SIE, SIES, GITMO groups.

Onida F, Barosi G, Leone G, Malcovati L, Morra E, Santini V, Specchia G, Tura S.

Haematologica. 2013 Sep;98(9):1344-52. doi: 10.3324/haematol.2013.084020. Review.

47.

Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda".

Molteni A, Riva M, Pellizzari A, Borin L, Freyrie A, Greco R, Ubezio M, Bernardi M, Fariciotti A, Nador G, Nichelatti M, Ravano E, Morra E.

Leuk Res. 2013 Oct;37(10):1233-40. doi: 10.1016/j.leukres.2013.07.006. Epub 2013 Jul 29. Erratum in: Leuk Res. 2014 Feb;38(2):267. Freyre, Alessandra [corrected to Freyrie, Alessandra].

PMID:
23906627
48.

Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Lo-Coco F, Avvisati G, Vignetti M, Thiede C, Orlando SM, Iacobelli S, Ferrara F, Fazi P, Cicconi L, Di Bona E, Specchia G, Sica S, Divona M, Levis A, Fiedler W, Cerqui E, Breccia M, Fioritoni G, Salih HR, Cazzola M, Melillo L, Carella AM, Brandts CH, Morra E, von Lilienfeld-Toal M, Hertenstein B, Wattad M, Lübbert M, Hänel M, Schmitz N, Link H, Kropp MG, Rambaldi A, La Nasa G, Luppi M, Ciceri F, Finizio O, Venditti A, Fabbiano F, Döhner K, Sauer M, Ganser A, Amadori S, Mandelli F, Döhner H, Ehninger G, Schlenk RF, Platzbecker U; Gruppo Italiano Malattie Ematologiche dell'Adulto; German-Austrian Acute Myeloid Leukemia Study Group; Study Alliance Leukemia.

N Engl J Med. 2013 Jul 11;369(2):111-21. doi: 10.1056/NEJMoa1300874.

49.

Should a positive direct antiglobulin test be considered a prognostic predictor in chronic lymphocytic leukemia?

Ricci F, Tedeschi A, Vismara E, Colombo C, Veronese S, Nichelatti M, Cairoli R, Morra E, Montillo M.

Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):441-6. doi: 10.1016/j.clml.2013.02.024. Epub 2013 Jun 14.

PMID:
23773451
50.

Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.

Cairoli R, Beghini A, Turrini M, Bertani G, Nadali G, Rodeghiero F, Castagnola C, Lazzaroni F, Nichelatti M, Ferrara F, Pizzolo G, Pogliani E, Rossi G, Martinelli G, Morra E.

Am J Hematol. 2013 Jul;88(7):594-600. doi: 10.1002/ajh.23461. Epub 2013 Jun 5.

Supplemental Content

Support Center